Home > Insider Trading > Filing (0001209191-20-059979)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1750284	Olema Pharmaceuticals Inc.	OLMA	Pharmaceutical Preparations (2834)	300409740

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1777517	Walmsley G. Graham	C/O Logos Global Management Lp 1 Letterman Drive, Bldg. D, Ste D3-700 San Francisco CA 94129		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-23	1,400,761	$0.00	1,400,761	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-11-23	1,183,114	$0.00	1,183,114	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-11-23	1,160,000	$19.00	1,160,000	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Disposition	2020-11-23	1,400,761	$0.00	1,400,761	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2020-11-23	1,183,114	$0.00	1,183,114	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

The shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into shares of Common Stock.
The shares are held by Logos Opportunities Fund I L.P. ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the Reporting Person is a managing member of Logos Opportunities GP. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares are held by Logos Opportunities Fund II, L.P. ("Logos Fund II"). Logos Opportunities GP is the general partner of Logos Fund II and the Reporting Person is a managing member of Logos Opportunities GP. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares are held by Logos Global Master Fund LP ("Logos Master Fund"). Logos GP LLC ("Logos GP") is the general partner of Logos Master Fund and the Reporting Person is a managing member of Logos GP. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.